ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care

Interstitial lung disease (ILD) is a collective term for a group of diseases where the lungs become scarred causing breathlessness. This research project will assess if remote digital monitoring of frequent spirometry and pulse oximetry can provide an additional way to monitor ILD and provide information to support virtual consultations. Outcomes in the remote monitoring group will be compared with usual care alone over 12 months. Patients taking part will be randomly allocated to remote digital monitoring or to usual care (with an equal chance of either). Remote monitoring will be performed using an app provided by patientMpower Ltd which patients will be able to download onto a smartphone or tablet. The study team will provide a spirometer and oximeter for patients to measure their lung function (spirometry) and oxygen saturations. These devices link to the app via Bluetooth to record all measurements. Patients will be asked to do these measurements three times a week. Clinical teams will be asked to review all measurements at least once a fortnight. Health outcomes will be described and compared between the two groups.

NCT Number	NCT05662124
Lead Sponsor	Imperial College Healthcare NHS Trust Collaborators: patientMpower Ltd., Imperial College London, University College, London, Action for Pulmonary Fibrosis
Conditions	Interstitial Lung Disease
Enrollment	139 participants
Start Date	2023-03-07
Primary Completion	2025-03 (estimated)
Study Completion	2025-04 (estimated)
Updated on ClinicalTrials.gov	2024-11-21